Precision Medicines is a clinical stage biotechnology company focused on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use. 

The development programs are focused on cancer sub types using a precision or personalised medicine approach, whereby therapies are co-developed with companion biomarkers to target the specific drivers of cancers.